T-Cell stimulation and regulation: With complements from CD46

Immunologic Research

Volumn 32, Issue 1-3, 2005, Pages 31-43

  Kemper, Claudia ^a   Verbsky, James W ^a   Price, Jeffrey D ^a   Atkinson, John P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD46; Complement; Immunosuppression; Interleukin 10; T regulatory T cells

Indexed keywords

CYTOKINE; GRANZYME B; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MEMBRANE COFACTOR PROTEIN; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; B LYMPHOCYTE; CELL CONTACT; CELL PROLIFERATION; COMPLEMENT SYSTEM; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 23844509111     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/ir:32:1-3:031     Document Type: Review

References (73)

1. Volanakis JE: Overview of the complement system; in Volanakis JE, Frank MM (eds): The Human Complement System in Health and Disease, 10th ed. New York, Marcel Dekker, 1998, pp 9-32.
2. Vogt W: Anaphylatoxins. Complement 1986;3:177-188.
3. Wetsel RA: Structure, function and cellular expression of complement anaphylatoxin receptors. Curr Opin Immunol 1995;7:48-53.
4. Carroll MC, Prodeus AP: Linkages of innate and adaptive immunity. Curr Opin Immunol 1998;10:36-40.
5. Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT: C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996;271:348-350.
6. Nielsen CH, Fischer EM, Leslie RG: The role of complement in the acquired immune response. Immunology 2000;100:4-12.
7. Prodeus AP, Goerg S, Shen LM, et al: A critical role for complement in maintenance of self-tolerance. Immunity 1998;9:721-731.
8. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003;421:388-392.
9. Sakaguchi S: Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000;101:455-458.
10. Shevach EM: Regulatory T cells in autoimmunity. Annu Rev Immunol 2000;18:423-449.
11. Bluestone JA, Abbas AK: Natural versus adapative regulatory T cells. Nat Rev Immunol 2003;3:253-257.
12. Jonuleit H, Schmitt E: The regulatory T cell family: distinct subsets and their interrelations. J Immunol 2003;171:6323-6327.
13. Fukaura H, Kent SC, Pietrusewicz ML, Khoury SJ, Weiner HL, Hafler DA: Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β 1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 1996;98:70-77.
14. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
15. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL: Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:1237-1240.
16. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188:287-296.
17. Roncarolo MG, Levings MK: The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opin Immunol 2000;12:676-683.
18. Liszewski MK, Post TW, Atkinson JP: Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu Rev Immunol 1991;9:431-455.
19. Barilla-LaBarca ML, Liszewski MK, Lambris J, Hourcade D, Atkinson JP: Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells. J Immunol 2002;168:6298-6304.
20. Rooney IA, Oglesby TJ, Atkinson JP: Complement in human reproduction: activation and control. Immunol Res 1993;12:276-294.
21. Riley RC, Kemper C, Leung M, Atkinson JP: Characterization of human membrane cofactor protein (MCP; CD46) on spermatozoa. Mol Reprod Dev 2002;62:534-546.
22. Dorig RE, Marcil A, Chopra A, Richardson CD: The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993;75:295-305.
23. Naniche D, Varior-Krishnan G, Cervoni F, et al: Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 1993;67:6025-6032.
24. Okada N, Liszewski MK, Atkinson JP, Caparon M: Membrane cofactor protein (MCP; CD46) is a keratinocyte receptor for the M protein of group A streptococcus. Proc Natl Acad Sci USA 1995;92:2489-2493.
25. Kallstrom H, Liszewski MK, Atkinson JP, Jonsson A-B: Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol Microbiol 1997;25:639-647.
26. Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P: CD46 is a cellular receptor for human herpes virus 6. Cell 1999;99:817-827.
27. Segerman A, Atkinson JP, Marttila M, Dennerquist V, Wadell G, Arnberg N: Adenovirus type 11 uses CD46 as a cellular receptor. J Virol 2002;77:9183-9191.
28. Gaggar A, Shayakhmetov DM, Lieber A: CD46 is a cellular receptor for group B adenoviruses. Nat Med 2003;9:1408-1412.
29. Cattaneo R: Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J Virol 2004;78:4385-4388.
30. Riley-Vargas RC, Gill DB, Kemper C, Liszewski MK, Atkinson JP: CD46: expanding beyond complement regulation. Trends Immunol 2004;25:496-503.
31. Karp CL, Wysocka M, Wahl LM, et al: Mechanism of suppression of cell-mediated immunity by measles virus [erratum appears in Science 1997;275(5303):1053]. Science 1996;273:228-231.
32. Kallstrom H, Islam MS, Berggren PO, Jonsson AB: Cell signaling by the type IV pili of pathogenic Neisseria. J Biol Chem 1998;273:21,777-21,782.
33. Kurita-Taniguchi M, Fukui A, Hazeki K, Hirano A, et al: Functional modulation of human macrophages through CD46 (measles virus receptor): production of IL-12 p40 and nitric oxide in association with recruitment of protein-tyrosine phosphatase SHP-1 to CD46. J Immunol 2000;165:5143-5152.
34. Hirano A, Kurita-Taniguchi M, Katayama Y, Matsumoto M, Wong TC, Seya T: Ligation of human CD46 with purified complement C3b or F(ab′)(2) of monoclonal antibodies enhances isoform-specific interferon gamma-dependent nitric oxide production in macrophages. J Biochem 2002;132:83-91.
35. Marie JC, Astier AL, Rivailler P, et al: Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell-induced inflammation. Nat Immunol 2002;3:659-666.
36. Wang G, Liszewski MK, Chan AC, Atkinson JP: Membrane cofactor protein (MCP; CD46): isoform-specific tyrosine phosphorylation. J Immunol 2000;164:1839-1846.
37. CBL and LAT phosphorylation. J Immunol 2000;164:6091-6095.
38. Zaffran Y, Destaing O, Roux A, et al: CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. J Immunol 2001;167:6780-6785.
39. + T cell suppressor function. J Immunol 2004;172:6519-6523.
40. Grossman WJ, Verbsky JW, Tollefsen BJ, Kemper C, Atkinson JP, Ley TJ: Differential expression of granzyme A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 2004;104:2840-2848.
41. Barry M, Bleackley RC: Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol 2002;2:401-409.
42. Malipiero U, Frei K, Spanaus KS, et al: Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perform knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice. Eur J Immunol 1997;27:3151-3160.
43. Arico M, Imashuku S, Clementi R, et al: Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene. Blood 2001;97:1131-1133.
44. Seya T, Hara T, Matsumoto M: Membrane cofactor protein (MCP, CD46) in seminal plasma and on spermatozoa in normal and "sterile" subjects. Eur J Immunol 1993;23:1322-1327.
45. Mestas J, Hughes CCW: Of mice and not men: differences between mouse and human immunology. J Immunol 2004;172:2731-2738.
46. Foley S, Li B, Dehoff M, Molina M, Holers VM: Mouse Crry/p65 is a regulator of the alternative pathway of complement activation. Eur J Immunol 1993;23:1381-1384.
47. Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H: A critical role for the murine complement regulator Crry in fetomaternal tolerance. Science 2000;287:498-501.
48. Kitamura M, Matsumiya K, Yamanaka M, et al: Possible association of infertility with sperm-specific abnormality of CD46. J Reprod Immunol 1997;33:83-88.
49. Nomura M, Kitamura M, Matsumiya K, et al: Genomic analysis of idiopathic infertile patients with sperm-specific depletion of CD46. Exp Clin Immunogenet 2001;18:42-50.
50. Oldstone MB, Lewicki H, Thomas D, et al: Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease. Cell 1999;98:629-640.
51. Kemper C, Leung M, Stephensen CB, et al: Membrane cofactor protein (MCP; CD46) expression in transgenic mice. Clin Exp Immunol 2001;124:180-189.
52. Horvat B, Rivailler P, Varior-Krishnan G, Cardoso A, Gerlier D, Rabourdin-Combe C: Transgenic mice expressing human measles virus (MV) receptor CD46 provide cells exhibiting different permissivities to MV infections. J Virol 1996;70:6673-6681.
53. Rall GF, Manchester M, Daniels LR, Callahan EM, Belman AR, Oldstone MBA: A transgenic mouse model for measles virus infection of the brain. Proc Natl Acad Sci USA 1997;94:4659-4663.
54. Evlashev A, Moyse E, Valentin H, et al: Productive measles virus brain infection and apoptosis in CD46 transgenic mice. J Virol 2000;74:1373-1382.
55. Evlashev A, Valentin H, Rivailler P, Azocar O, Rabourdin-Combe C, Horvat B: Differential permissivity to measles virus infection of human and CD46-transgenic murine lymphocytes. J Gen Virol 2001;82:2125-2129.
56. Hourcade D, Holers VM, Atkinson JP: The regulators of complement activation (RCA) gene cluster. Adv Immunol 1989;45:381-416.
57. Mrkic B, Pavlovic J, Rulicke T, et al: Measles virus spread and pathogenesis in genetically modified mice. J Virol 1998;72:7420-7427.
58. Yannoutsos N, Ijzermans JNM, Harkes C, et al: A membrane cofactor protein transgenic mouse model for the study of discordant xenograft rejection. Genes Cell 1996;1409-1419.
59. Thorley BR, Milland J, Christiansen D, et al: Transgenic expression of a CD46 (membrane cofactor protein) minigene: studies of xenotransplantation and measles virus infection. Eur J Immunol 1997;27:726-734.
60. Blixenkrone-Moeller M, Bernard A, Bencsik A, et al: Role of CD46 in measles virus infection in CD46 transgenic mice. Virology 1998;249:238-248.
61. Johansson L, Rytkonen A, Bergman P, et al: CD46 in meningococcal disease. Science 2003;301:373-375.
62. Stevens DL: Invasive group A streptococcal infections. Clin Infect Dis 1992;14:2-11.
63. Giannakis E, Jokiranta TS, Ormsby RI, et al: Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46). J Immunol 2002;168:4585-4592.
64. Mittrücker H-W, Kaufmann SHE: Regulatory T cells and infection: suppression revisited. Eur J Immunol 2004;34:306-312.
65. McGuirk P, McCann C, Mills KHG: Pathogen-specific T-regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 2002;195:221-231.
66. Lavelle EC, McNeela E, Armstrong ME, Leavy O, Higgins SC, Mills KHG: Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation. J Immunol 2003;171:2384-2392.
67. Riley RC, Tannenbaum PL, Abbott DH, Atkinson JP: Cutting edge: inhibiting measles virus infection but promoting reproduction: an explanation for splicing and tissue-specific expression of CD46. J Immunol 2002;169:5405-5409.
68. Manchester M, Gairin JE, Alvarez J, Liszewski MK, Atkinson JP, Oldstone MBA: Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2. Virology 1997;233:174-184.
69. + suppressor T cells: more questions than answers. Nat Rev Immunol 2002;2:389-400.
70. Akbari O, Stock P, DeKruyff RH, Umetsu DT: Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2003;8:1024-1032.
71. H3 regulatory cells. Nat Immunol 2001;2:671-672.
72. + T cell down-regulation in human intestinal mucosa: evidence for intestinal tolerance to luminal bacterial antigens. J Immunol 1997;158:3626-3634.
73. Papiemik M, de Moraes ML, Pontoux C, Vasseur F, Penit C: Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 1998;10:371-378.